Sadiq Khan - 14 Feb 2024 Form 4 Insider Report for Semper Paratus Acquisition Corp (TVGN)

Role
Chief Commercial Officer
Signature
/s/ Kirti Desai, Attorney-in-Fact
Issuer symbol
TVGN
Transactions as of
14 Feb 2024
Net transactions value
$0
Form type
4
Filing time
16 Feb 2024, 17:24:32 UTC
Next filing
01 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVGN Common Stock Award +969,618 969,618 14 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer.